The integration of a plate reader into Eppendorf’s epMotion liquid handling system facilitates researchers to use the system in a variety of new applications. The current focus is on absorption-based measurements and analysis. Initial findings are centered around protein quantification, cell assays, and bacterial assay. As with all other automation applications, the main emphasis of these efforts is on the efficiency, accuracy, and versatility of automated laboratory processes. The objective is to provide a first-class user experience with maximum precision during automated workflow.


This was made possible by integrating a new class of on-deck absorbance plate readers featuring a compact footprint and fast readout, manufactured by Byonoy, an innovative biotech company specializing in modern measurement instrumentation. The integration of the pioneering on-deck plate reader, Absorbance 96 Automate into the range of powerful and proven liquid handling systems of Eppendorf’s epMotion series is remarkably easy and simple. This integration enables researchers to effortlessly conduct plate readings and analysis during any automated laboratory processes.


“By integrating Byonoy's compact plate readers into our epMotion liquid handling system, we intend to raise the standards for precision and efficiency in scientific research. The initial results presented in the course of 2024’s SLAS conference are the starting point for a promising collaboration that will improve the researchers’ and scientists’ performance around the world.” Dr. Josef Lott, Product Manager Automated Liquid Handling, Eppendorf SE.

“Collaboration with Eppendorf opens new opportunities for researchers and provides access to state-of-the-art automated detection solutions by seamlessly integrating our innovative on-deck plate readers into Eppendorf's robust liquid handling system. Focusing on automated absorption-based assays is just the beginning. We are very curious to see the progress we will make in the coming months as we expand our collaboration into the field of automated luminescence-based applications.” Dr. Yousef Nazirizadeh, CEO, Byonoy.


About Byonoy

With a passion for reenvision laboratories, Byonoy has been at the forefront of reshaping lab measurement instrumentation with its modern microplate readers, offering enhanced usability, and compactness with high-performance precision. Byonoy stands as a key player in streamlining laboratory workflows across various detection methods with versatile applications ranging from biotech, pharma, and agriculture to the analytical sector. Collaborating with leading industry partners and universities globally, Byonoy is dedicated to fostering accessibility to cutting-edge measurement technologies, contributing to advancements in scientific research.

www.byonoy.com

About the Eppendorf Group

Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world.

The product portfolio of the business units Liquid Handling, Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2022, the Eppendorf Group generated €1.23 billion in sales and invested €76 million in research and development (R&D).

Eppendorf products are used in academic and industrial research laboratories, for example in companies in the pharmaceutical, biotech, chemical and food industries. But Eppendorf products are also used in clinical or environmental analysis laboratories, in forensics and in industrial laboratories for process analysis, production, and quality assurance.

Eppendorf was founded in 1945, is headquartered in Hamburg, Germany, operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 33 countries. Today, the Group employs more than 5,000 people worldwide. They all act in accordance with the purpose of the company's founders: to improve human living conditions. 

Zrzut ekranu 2023 10 11 o 13.29.27

Back to top